3Moore KP,Wong F,Gines P,et al.The management of ascites in cirrhosis:report on the consensus conference of the International Ascites Club.Hepatology,2003,38:258-266.
4Gines P,Cardenas A,Arroyo V,et al.Management of cirrhosis and ascites.N Engl J Med,2004,350:1646-1654.
5Gadano A,Moreau R,Vachiery F,et al.Natriuretic response to the combination of atrial natriuretic peptide and terlipressin inpatients with cirrhosis and refractory ascites.J Hepatol,1997,26:1229-1234.
6Costello-Boerrigter LC,Boerrigter G,Burnett JC Jr.Revisiting salt and water retention:new diuretics,aquaretics,and natriuretics.Med Clin NorthAm,2003,87:475-491.
7Janicic N,Verbalis JG.Evaluation and management of hypoosmolality in hospitalized patients.Endocrinol Metab Clin North Am,2003,32:459-481,vii.
8Serradeil-Le Gal C.An overview of SR121463,a selective nonpeptide vasopressin V(2) receptor antagonist.Cardiovasc Drug Rev,2001,19:201-214.
10Salerno F,Merli M,Riggio O,et al.Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.Hepatology,2004,40:629-635.
